University of Virginia - icddr,b Research Unit for Women's and Children's Health Research
弗吉尼亚大学 - icddr,b 妇女和儿童健康研究单位
基本信息
- 批准号:10413887
- 负责人:
- 金额:$ 30.17万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-08-01 至 2023-08-09
- 项目状态:已结题
- 来源:
- 关键词:AddressAdoptionAfricanAsianBangladeshBirth WeightCessation of lifeChildChild DevelopmentChild HealthChronicClinicalClinical ProtocolsClinical ResearchClinical TrialsClinical trial protocol documentCollaborationsCommunicable DiseasesCommunitiesComplementCoordination and CollaborationCountryDataDevelopmentDevelopmental Delay DisordersDiarrheaEnteralEnvironmentFacility AccessesFunctional disorderGoalsGovernmentGrantHealthHealth StatusHuman GeneticsImmunologyImpairmentIncomeInfant MalnutritionInfectionInflammationInstitutesInternationalInterventionKnowledgeLeadLeadershipLive BirthMalnutritionMaternal MortalityMaternal and Child HealthMaternal-fetal medicineModelingMothersMucous MembraneNeonatal MortalityNeonatologyNeurocognitiveObservational StudyOralParasitologyPositioning AttributePregnancyPregnant WomenPrincipal InvestigatorPublic HealthPublicationsRecording of previous eventsRehydration SolutionsResearchResearch Peer ReviewResearch PersonnelRespiratory Tract InfectionsRoleRotavirus VaccinesRuralRural PopulationScientistSiteSustainable DevelopmentTestingUnited NationsUniversitiesUrban PopulationVirginiaWeight GainWomanWorkauthoritybasecommunity based caredietary supplementsexperienceglobal healthimprovedinfant nutritioninnovationinventionlaboratory facilitymicrobiomemolecular diagnosticsmortalitymultidisciplinaryneonatal healthneurodevelopmentnovelnutritionoral vaccinepollutantpopulation healthpreventvaccine failurevaccinology
项目摘要
Project Summary
We propose that the University of Virginia (UVa) and icddr,b become a Research Unit (RU) within the Global
Network for Women's and Children's Health Research.
Significance: Mothers and children in Bangladesh and other low-mid income countries suffer disproportionately
from maternal and infant malnutrition, neonatal mortality from diarrhea and respiratory infections, vaccine
failure and impaired child development. The UVa-icddrb Research Unit (RU) will address these critical needs
of women and young children by complementing the existing Network strengths with added scientific expertise
in infectious diseases, neurocognitive development, human genetics, maternal-fetal medicine, immunology,
and vaccinology. The RU will also provide extraordinary access to rural and urban populations for clinical trials.
Investigators: The RU Principal Investigator (PI) William Petri and Senior Foreign Investigator (SFI) Rashidul
Haque have for 25 years co-led multidisciplinary teams studying maternal-child, with over 100 co-publications
and eight on-going clinical trials or observational studies. They are joined at icddr,b by a multidisciplinary team
of F. Qadri (Immunology), K. Zaman (Vaccinology), F. Tofail (Child Development), M. Billah and S. El Arifeen
(Maternal and Child Health), T. Ahmed (infant nutrition) and at UVa by C. Chisholm (ob/gyn) and R. Sinkin
(neonatology).
Innovation: The RU has a long history of innovative studies and expertise in maternal-child health, including
the impact of infection and inflammation on child neurocognitive development, role of airborne pollutants on
respiratory infection, function of gut damage in oral vaccine failure and malnutrition.
Approach: The RU will work within the Network to promote innovative studies that have the potential to lead to
actionable and sustainable improvement in maternal and child health through the partnership of the RU with
the government of Bangladesh (manifest through the worldwide implementation of oral rehydration solution,
discovered at icddr,b and adoption nationwide of the Matlab model of community based care).
Environment: The RU has unparalleled multidisciplinary strength, laboratory facilities and access to urban
and rural populations of mothers and children. The icddr,b is one of the foremost global health institutes in
the developing world with over 200 active clinical trials/protocols. The UVa Division of Infectious Diseases
and International Health is the largest research unit at UVa with over $20 million in annual grant support and
over two dozen active clinical protocols. The quarter of a century UVa-icddrb collaboration and unique and
complementary expertise promises to bring unparalleled strengths to the Network's goal of making
sustainable improvements in maternal and child health.
项目概要
我们建议弗吉尼亚大学 (UVa) 和 icddr,b 成为全球研究中心 (RU)
妇女和儿童健康研究网络。
意义:孟加拉国和其他中低收入国家的母亲和儿童遭受的苦难尤为严重
孕产妇和婴儿营养不良、腹泻和呼吸道感染导致的新生儿死亡、疫苗
失败和儿童发育受损。 UVa-icddrb 研究单位 (RU) 将满足这些关键需求
通过增加科学专业知识来补充现有网络优势,从而保护妇女和幼儿
在传染病、神经认知发育、人类遗传学、母胎医学、免疫学、
和疫苗学。 RU 还将为农村和城市人口提供临床试验的非凡机会。
调查人员:RU 首席调查员 (PI) William Petri 和高级外国调查员 (SFI) Rashidul
Haque 25 年来一直共同领导多学科团队研究母婴,并发表了 100 多篇联合出版物
以及八项正在进行的临床试验或观察性研究。他们由多学科团队加入 icddr,b
F. Qadri(免疫学)、K. Zaman(疫苗学)、F. Tofail(儿童发展)、M. Billah 和 S. El Arifeen 教授
(妇幼健康)、T. Ahmed(婴儿营养)以及 UVa 的 C. Chisholm(妇产科)和 R. Sinkin
(新生儿学)。
创新:RU 在母婴健康方面拥有悠久的创新研究和专业知识历史,包括
感染和炎症对儿童神经认知发育的影响,空气污染物的作用
呼吸道感染、口服疫苗失败和营养不良中肠道功能受损。
方法:RU 将在网络内开展工作,促进有潜力带来成果的创新研究
通过与 RU 的合作,切实可行且可持续地改善孕产妇和儿童健康
孟加拉国政府(通过在全球范围内实施口服补液盐来体现,
icddr,b 发现并在全国范围内采用社区护理的 Matlab 模型)。
环境: RU 拥有无与伦比的多学科实力、实验室设施和通往城市的通道
以及农村人口的母亲和儿童。 icddr,b 是世界上最重要的全球卫生机构之一
发展中国家有超过 200 个活跃的临床试验/方案。弗吉尼亚大学传染病科
国际健康是弗吉尼亚大学最大的研究单位,每年提供超过 2000 万美元的资助支持
超过两打活跃的临床方案。 UVa-icddrb 四分之一个世纪的合作和独特且
互补的专业知识有望为网络的目标带来无与伦比的优势
可持续改善孕产妇和儿童健康。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
William A Petri其他文献
The impact of existing total anti-toxin B IgG immunity in outcomes of recurrent Clostridioides difficile infection.
现有总抗毒素 B IgG 免疫力对复发性艰难梭菌感染结果的影响。
- DOI:
10.1016/j.anaerobe.2024.102842 - 发表时间:
2024-03-01 - 期刊:
- 影响因子:2.3
- 作者:
Isaura Rigo;Mary K Young;Mayuresh M. Abhyankar;Feifan Xu;Girija Ramakrishnan;Farha Naz;William A Petri;Gregory R Madden - 通讯作者:
Gregory R Madden
Hyaluronan deposition during COVID-19 - helpful or harmful?
COVID-19 期间透明质酸沉积 - 有益还是有害?
- DOI:
10.1016/j.molmed.2024.01.003 - 发表时间:
2024-02-01 - 期刊:
- 影响因子:13.6
- 作者:
Duncan Hart;William A Petri - 通讯作者:
William A Petri
Pulmonary function and survival one year after dupilumab treatment of acute moderate to severe COVID-19: A follow up study from a Phase IIa trial
Dupilumab 治疗急性中度至重度 COVID-19 一年后的肺功能和生存率:IIa 期试验的后续研究
- DOI:
10.1101/2023.09.01.23293947 - 发表时间:
2023-09-02 - 期刊:
- 影响因子:0
- 作者:
Jennifer Hendrick;Jennie Z. Ma;H. Haughey;Rachael Coleman;Uma Nayak;A. Kadl;Jeffrey M. Sturek;Patrick E. H. Jackson;M. Young;Judi Allen;William A Petri - 通讯作者:
William A Petri
Genomic Heterogeneity of Cryptosporidium parvum Isolates From Children in Bangladesh: Implications for Parasite Biology and Human Infection
从孟加拉国儿童中分离出的隐孢子虫的基因组异质性:对寄生虫生物学和人类感染的影响
- DOI:
- 发表时间:
2023 - 期刊:
- 影响因子:6.4
- 作者:
Maureen Carey;Tuhinur Arju;James A Cotton;Masud Alam;M. Kabir;A. Faruque;R. Haque;William A Petri;C. Gilchrist - 通讯作者:
C. Gilchrist
Systemic neutrophil degranulation and emergency granulopoiesis in patients with Clostridioides difficile infection.
艰难梭菌感染患者的全身中性粒细胞脱粒和紧急粒细胞生成。
- DOI:
10.1016/j.anaerobe.2024.102840 - 发表时间:
2024-03-01 - 期刊:
- 影响因子:2.3
- 作者:
Girija Ramakrishnan;Mary K Young;Uma Nayak;Isaura Rigo;Andrea S. Marrs;Carol A. Gilchrist;Brian W. Behm;Gregory R Madden;William A Petri - 通讯作者:
William A Petri
William A Petri的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('William A Petri', 18)}}的其他基金
Role of Th17 in Severe and Recurrent C. difficile Infection
Th17 在严重和复发性艰难梭菌感染中的作用
- 批准号:
10443698 - 财政年份:2020
- 资助金额:
$ 30.17万 - 项目类别:
Role of Th17 in Severe and Recurrent C. difficile Infection
Th17 在严重和复发性艰难梭菌感染中的作用
- 批准号:
10653065 - 财政年份:2020
- 资助金额:
$ 30.17万 - 项目类别:
Role of Th17 in Severe and Recurrent C. difficile Infection
Th17 在严重和复发性艰难梭菌感染中的作用
- 批准号:
10223165 - 财政年份:2020
- 资助金额:
$ 30.17万 - 项目类别:
University of Virginia - icddr,b Research Unit for Women's and Children's Health Research
弗吉尼亚大学 - icddr,b 妇女和儿童健康研究单位
- 批准号:
10176548 - 财政年份:2018
- 资助金额:
$ 30.17万 - 项目类别:
University of Virginia - icddr,b Research Unit for Women's and Children's Health Research
弗吉尼亚大学 - icddr,b 妇女和儿童健康研究单位
- 批准号:
9754231 - 财政年份:2018
- 资助金额:
$ 30.17万 - 项目类别:
NICHD Global Network for Women’s and Children’s Health Research: Research Units
NICHD 全球妇女和儿童健康研究网络:研究单位
- 批准号:
10746195 - 财政年份:2018
- 资助金额:
$ 30.17万 - 项目类别:
Role of Type 2 Immunity in Innate Protection from C. difficile
2 型免疫在艰难梭菌先天保护中的作用
- 批准号:
10467414 - 财政年份:2016
- 资助金额:
$ 30.17万 - 项目类别:
Role of Type 2 Immunity in Innate Protection from C. difficile
2 型免疫在艰难梭菌先天保护中的作用
- 批准号:
10561651 - 财政年份:2016
- 资助金额:
$ 30.17万 - 项目类别:
Role of IL-23 in the Immunopathogenesis of C. difficile colitis
IL-23 在艰难梭菌结肠炎免疫发病机制中的作用
- 批准号:
9057951 - 财政年份:2015
- 资助金额:
$ 30.17万 - 项目类别:
相似国自然基金
山丘区农户生计分化对水保措施采用的影响及其调控对策
- 批准号:42377321
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
采用新型视觉-电刺激配对范式长期、特异性改变成年期动物视觉系统功能可塑性
- 批准号:32371047
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
金融科技驱动的供应链库存与融资策略和技术采用合作机制研究
- 批准号:72371117
- 批准年份:2023
- 资助金额:39 万元
- 项目类别:面上项目
政策激励、信息传递与农户屋顶光伏技术采用提升机制研究
- 批准号:72304103
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
金属有机骨架材料在环境VOCs处理过程中采用原位电子顺磁共振自旋探针检测方法的研究
- 批准号:22376147
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
相似海外基金
Screening strategies for sexually transmitted infections in a high HIV incidence setting in South Africa
南非艾滋病毒高发地区的性传播感染筛查策略
- 批准号:
10761853 - 财政年份:2023
- 资助金额:
$ 30.17万 - 项目类别:
ARISE (Achieving Routine Intervention and Screening for Emotional health)
ARISE(实现情绪健康的常规干预和筛查)
- 批准号:
10655877 - 财政年份:2023
- 资助金额:
$ 30.17万 - 项目类别:
mAnaging siCkle CELl disease through incReased AdopTion of hydroxyurEa in Nigeria (ACCELERATE)
在尼日利亚通过增加羟基脲的使用来控制镰状细胞病(加速)
- 批准号:
10638598 - 财政年份:2023
- 资助金额:
$ 30.17万 - 项目类别:
Mitigating the Effects of Structural Racism on Chronic Kidney Disease Disparities among African Americans
减轻结构性种族主义对非裔美国人慢性肾病差异的影响
- 批准号:
10742680 - 财政年份:2023
- 资助金额:
$ 30.17万 - 项目类别:
Improving cross ancestry polygenic prediction of tobacco and alcohol use
改进烟草和酒精使用的跨血统多基因预测
- 批准号:
10739557 - 财政年份:2023
- 资助金额:
$ 30.17万 - 项目类别: